FR2343251A1 - Procede pour enlever selectivement les lipoproteines du plasma ou du serum sanguin - Google Patents

Procede pour enlever selectivement les lipoproteines du plasma ou du serum sanguin

Info

Publication number
FR2343251A1
FR2343251A1 FR7706286A FR7706286A FR2343251A1 FR 2343251 A1 FR2343251 A1 FR 2343251A1 FR 7706286 A FR7706286 A FR 7706286A FR 7706286 A FR7706286 A FR 7706286A FR 2343251 A1 FR2343251 A1 FR 2343251A1
Authority
FR
France
Prior art keywords
plasma
procedure
blood serum
selectively removing
removing lipoproteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7706286A
Other languages
English (en)
Other versions
FR2343251B3 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Development Finance Corp of New Zealand
Original Assignee
Development Finance Corp of New Zealand
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Development Finance Corp of New Zealand filed Critical Development Finance Corp of New Zealand
Publication of FR2343251A1 publication Critical patent/FR2343251A1/fr
Application granted granted Critical
Publication of FR2343251B3 publication Critical patent/FR2343251B3/fr
Granted legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/08—Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/16—Organic material
    • B01J39/18—Macromolecular compounds
    • B01J39/22—Cellulose or wood; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J47/00—Ion-exchange processes in general; Apparatus therefor
    • B01J47/014—Ion-exchange processes in general; Apparatus therefor in which the adsorbent properties of the ion-exchanger are involved, e.g. recovery of proteins or other high-molecular compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/491—Blood by separating the blood components
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Ecology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
FR7706286A 1976-03-04 1977-03-03 Procede pour enlever selectivement les lipoproteines du plasma ou du serum sanguin Granted FR2343251A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ180199A NZ180199A (en) 1976-03-04 1976-03-04 Method of testing for the presence of elevated plasma liprotein concentration

Publications (2)

Publication Number Publication Date
FR2343251A1 true FR2343251A1 (fr) 1977-09-30
FR2343251B3 FR2343251B3 (fr) 1980-02-15

Family

ID=19917635

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7706286A Granted FR2343251A1 (fr) 1976-03-04 1977-03-03 Procede pour enlever selectivement les lipoproteines du plasma ou du serum sanguin

Country Status (9)

Country Link
US (1) US4096136A (fr)
JP (1) JPS52125396A (fr)
AU (1) AU2279777A (fr)
DE (1) DE2708912C2 (fr)
FR (1) FR2343251A1 (fr)
GB (2) GB1543016A (fr)
IT (1) IT1115552B (fr)
NZ (1) NZ180199A (fr)
SE (1) SE447873B (fr)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2406825A1 (fr) * 1977-10-22 1979-05-18 Mitsubishi Chem Ind Procede et appareillage pour le dosage du glucose
EP0137221A2 (fr) * 1983-08-25 1985-04-17 BEHRINGWERKE Aktiengesellschaft Procédé pour séparer des lipoprotéines au moyen de dérivés de polyhydroxyméthylène
EP0180168A2 (fr) * 1984-10-31 1986-05-07 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Adsorbant de lipoprotéines utilisé pour le traitement en circulation extracorporelle
FR2573997A1 (fr) * 1984-12-03 1986-06-06 Commissariat Energie Atomique Support solide capable d'adsorber des lipoproteines et son utilisation pour la separation des lipoproteines de basse densite presentes dans un liquide tel que le plasma sanguin
EP0187670A2 (fr) * 1985-01-11 1986-07-16 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Procédé pour récupérer un adsorbant utilisé dans le traitement de circulation extracorporelle
FR2586359A1 (fr) * 1985-08-23 1987-02-27 Commissariat Energie Atomique Support solide a base d'alcool polyvinylique capable d'adsorber les lipoproteines et son utilisation pour la separation des lipoproteines de basse densite presentes dans un liquide tel que du plasma sanguin
EP0225867A2 (fr) * 1982-12-02 1987-06-16 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Adsorbant et procédé de préparation
EP0319250A1 (fr) * 1987-12-03 1989-06-07 Ov Limited Procédé pour l'estimation des concentrations du cholestérol systémique dans les échantillons du sang capillaire
EP0329605A1 (fr) * 1988-02-08 1989-08-23 Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk Procédé pour la préparation d'apolipoprotéines à partir des fractions de plasma ou sérum de sang

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4190628A (en) * 1977-11-21 1980-02-26 Trustees Of Boston University Kit for determining the level of LDL cholesterol in body fluids
DE2963844D1 (en) * 1978-07-04 1982-11-18 Goella Lab Method and reagents for measuring the cholesterol content in serum
US4188188A (en) * 1978-09-27 1980-02-12 Bio-Rad Laboratories, Inc. High density lipoprotein cholesterol assay
US4228154A (en) * 1979-02-26 1980-10-14 Armour Pharmaceutical Company Purification of plasma albumin by ion exchange chromatography
US4264471A (en) * 1979-06-04 1981-04-28 E. I. Du Pont De Nemours And Company Serum and plasma clarification process
GB2061282B (en) * 1979-10-22 1983-03-30 Symphar Sa Method for the clinical separation of a-and lipoproteins and kit for carrying out this method
US4290774A (en) * 1980-01-07 1981-09-22 Miles Laboratories, Inc. Purification of lipoprotein cholesterol for use as a cholesterol reference material
DE3007764A1 (de) * 1980-02-29 1981-10-15 Boehringer Mannheim Gmbh Verfahren und reagens zur bestimmung der beta -lipoproteine
DE3009037A1 (de) * 1980-03-08 1981-09-24 Boehringer Mannheim Gmbh Verfahren zur direkten bestimmung des lipidgehaltes der (beta) -lipoproteine des blutes
DE3135814A1 (de) * 1981-09-10 1983-03-24 B. Braun Melsungen Ag, 3508 Melsungen Verfahren und vorrichtung zur selektiven extrakorporalen praezipitation von low density lipoproteinen aus vollserum oder plasma
JPS58187859A (ja) * 1982-04-26 1983-11-02 Kyoto Daiichi Kagaku:Kk 血小板粘着能の測定方法
US4439358A (en) * 1982-06-17 1984-03-27 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
NZ208241A (en) * 1984-05-22 1987-09-30 John Stephen Ayers Purification of blood plasma or serum: selective removal of (very) low density lipoproteins (ldl and vldl)
DE3422407A1 (de) * 1984-06-16 1986-03-06 B. Braun Melsungen Ag, 3508 Melsungen Verwendung von heparinderivaten zur selektiven extrakorporalen praezipitation von low-density-lipoproteinen aus vollserum oder plasma
US4683294A (en) * 1985-04-03 1987-07-28 Smith Kline Rit, S.A. Process for the extraction and purification of proteins from culture media producing them
SE456136B (sv) * 1985-06-17 1988-09-12 Oncholab Ab Forfarande for framstellning av en med ett lipofilt biologiskt aktivt emne bemengd berare pa basis av rekonstituerat ldl (lagdensitetslipoprotein)
JPH0725800B2 (ja) * 1987-04-10 1995-03-22 雪印乳業株式会社 硫酸エステル化物を用いて乳からラクトフエリンを分離、精製する方法
US5110907A (en) * 1989-08-01 1992-05-05 Alpha Therapeutic Corporation Factor viii complex purification using heparin affinity chromatography
US5344571A (en) * 1992-02-18 1994-09-06 University Of Texas System Board Of Regents Method for separating isoanalytes and measuring analytes in fluids
EP0663073A1 (fr) * 1992-09-24 1995-07-19 Perseptive Biosystems, Inc. Mesure quantitative de lipoproteines de faible densite (ldl)
JP4644948B2 (ja) * 2000-02-04 2011-03-09 東ソー株式会社 リポ蛋白質分析方法
US6706008B2 (en) 2001-03-06 2004-03-16 Baxter International Inc. Automated system and method for withdrawing compounds from blood
US6582386B2 (en) * 2001-03-06 2003-06-24 Baxter International Inc. Multi-purpose, automated blood and fluid processing systems and methods
US6884228B2 (en) 2001-03-06 2005-04-26 Baxter International Inc. Automated system adaptable for use with different fluid circuits
US7022744B2 (en) * 2002-04-11 2006-04-04 Mitsubishi Chemical Corporation Ion exchanger for lipoproteins separation and lipoproteins separation method using the same
DE102004009400A1 (de) * 2004-02-24 2005-09-08 Zlb Behring Gmbh Fibrinogen Reinigung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562289A (en) * 1965-05-12 1971-02-09 Fmc Corp Chromatographic separation process by means of cellulose crystallite aggregates derivatives
US3573277A (en) * 1968-07-15 1971-03-30 Tasman Vaccine Labor Ltd Cellulosic ion exchange materials and method of making
US3838143A (en) * 1968-07-15 1974-09-24 Tasman Vaccine Labor Ltd Processes for the recovery of protein from waste effluents using regenerated cellulose ion-exchange resins
SE392038B (sv) * 1971-09-08 1977-03-14 Kabi Ab Forfarande for isolering av antitrombin ur blod eller blodprodukter
US3920625A (en) * 1973-06-19 1975-11-18 Kabi Ab Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2406825A1 (fr) * 1977-10-22 1979-05-18 Mitsubishi Chem Ind Procede et appareillage pour le dosage du glucose
EP0225867A3 (en) * 1982-12-02 1988-02-24 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Adsorbent and process for preparing the same
EP0225867A2 (fr) * 1982-12-02 1987-06-16 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Adsorbant et procédé de préparation
EP0137221A2 (fr) * 1983-08-25 1985-04-17 BEHRINGWERKE Aktiengesellschaft Procédé pour séparer des lipoprotéines au moyen de dérivés de polyhydroxyméthylène
EP0137221A3 (en) * 1983-08-25 1987-11-04 Behringwerke Aktiengesellschaft Process for separating lipoproteins bv means of derived polyhydroxymethylene
EP0180168A2 (fr) * 1984-10-31 1986-05-07 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Adsorbant de lipoprotéines utilisé pour le traitement en circulation extracorporelle
EP0180168A3 (en) * 1984-10-31 1987-02-04 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Lipoprotein adsorbent for use in extracorporeal circulation treatment and process for preparing thereof
FR2573997A1 (fr) * 1984-12-03 1986-06-06 Commissariat Energie Atomique Support solide capable d'adsorber des lipoproteines et son utilisation pour la separation des lipoproteines de basse densite presentes dans un liquide tel que le plasma sanguin
EP0187670A3 (fr) * 1985-01-11 1987-04-08 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Procédé pour récupérer un adsorbant utilisé dans le traitement de circulation extracorporelle
EP0187670A2 (fr) * 1985-01-11 1986-07-16 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Procédé pour récupérer un adsorbant utilisé dans le traitement de circulation extracorporelle
EP0216668A1 (fr) * 1985-08-23 1987-04-01 Société anonyme: COMPAGNIE ORIS INDUSTRIE Support solide à base d'alcool polyvinylique capable d'absorber les lipoprotéines et son utilisation pour la séparation des lipoprotéines de basse densité présentes dans un liquide tel que du plasma sanguin
FR2586359A1 (fr) * 1985-08-23 1987-02-27 Commissariat Energie Atomique Support solide a base d'alcool polyvinylique capable d'adsorber les lipoproteines et son utilisation pour la separation des lipoproteines de basse densite presentes dans un liquide tel que du plasma sanguin
US4781838A (en) * 1985-08-23 1988-11-01 Commissariat A L'energie Atomique Solid polyvinyl alcohol-based support able to adsorb lipoproteins and its use for the separation of low density lipoproteins present in a liquid, such as blood plasma
EP0319250A1 (fr) * 1987-12-03 1989-06-07 Ov Limited Procédé pour l'estimation des concentrations du cholestérol systémique dans les échantillons du sang capillaire
WO1989005458A1 (fr) * 1987-12-03 1989-06-15 Oxford Virology Limited Procede servant a estimer les concentrations de cholesterol dans le sang
EP0329605A1 (fr) * 1988-02-08 1989-08-23 Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk Procédé pour la préparation d'apolipoprotéines à partir des fractions de plasma ou sérum de sang

Also Published As

Publication number Publication date
GB1573512A (en) 1980-08-28
US4096136A (en) 1978-06-20
AU2279777A (en) 1978-09-07
DE2708912A1 (de) 1977-09-08
DE2708912C2 (de) 1986-10-16
GB1543016A (en) 1979-03-28
FR2343251B3 (fr) 1980-02-15
SE7702324L (sv) 1977-09-05
IT1115552B (it) 1986-02-03
JPS6248193B2 (fr) 1987-10-13
JPS52125396A (en) 1977-10-21
NZ180199A (en) 1978-11-13
SE447873B (sv) 1986-12-22

Similar Documents

Publication Publication Date Title
FR2343251A1 (fr) Procede pour enlever selectivement les lipoproteines du plasma ou du serum sanguin
AT363063B (de) Vorrichtung zum abscheiden von fluessigkeitstropfen
BE849184A (fr) Procede et dispositif pour etablir la presence de sang occulte
DE3381283D1 (de) Vorrichtung zur serumabscheidung aus blut.
FR2344514A1 (fr) Procede pour le recueil de xylitol
NL173558C (nl) Aftapinrichting voor vloeistof-monsters.
BE860377A (fr) Procede pour fractionner les elements figures du sang
BE866621A (fr) Procede pour inhiber la formation du pollen
IT1077655B (it) Procedimento e dispositivo per separare sostanze mediante centrifugazione
IT1156191B (it) Dispositivo per la separazione di liquidi insolubili tra loro da miscele
NO773294L (no) Anordning for aa fjerne faststoffer fra vaesker
BE858640A (fr) Procede pour la preparation de methoxypsoralene
LU78847A1 (fr) Procede pour separer le mannose du glucose
BE855936A (fr) Procede de separation du platine et/ou du palladium
BE880629A (fr) Dispositif de separation de fluides
BE850950A (fr) Procede pour enlever le mercure
FR2299323A1 (fr) Procede pour la separation de 4,4'-dichlorodiphenylsulfone
BE857926A (fr) Procede de separation de melanges de dinitroanthraquinones
NL7610839A (nl) Monsterbuisje voor vloeistofmonsters.
DK342581A (da) Apparat til at udtage fosterblod inutero
RO71263A (fr) Procede pour la separation d'isobutyllene de melanges de hydrocarbures
SU692614A1 (ru) Устройство дл отделени газа от жидкости
FR2338235A1 (fr) Solvant pour la separation des hydrocarbures
JPS5643931A (en) Blood taking pipe for serum separation
RO85813A (fr) Procede pour la preparation du dimere vinca